Last updated on February 2019

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata


Brief description of study

This study is designed to select up to two doses of baricitinib (referred to as low dose and high dose) and assess their efficacy and safety for the treatment of severe or very severe alopecia areata.

Clinical Study Identifier: NCT03570749

Contact Investigators or Research Sites near you

Start Over

Chang Hun Huh

Seoul National University Bundang Hospital
Seongnam-si, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.